Nobizide (Hydrochlorothiazide, Nebivolol)

Hydrochlorothiazide / Nebivolol, the active ingredient in Nobizide, is a thiazide diuretic and beta‑blocker presented as an oral tablet for oral use. It treats hypertension in adult patients by reducing blood pressure through diuresis and β1‑adrenergic blockade, helping to lower cardiovascular risk and improve long‑term blood‑pressure control.

GNH USA supplies Nobizide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable bulk shipments and regulatory support for global markets.

Nobizide, a combination antihypertensive, is used to manage elevated blood pressure in various clinical settings.

Essential hypertension: reduces systolic and diastolic pressure to target levels Primary hypertension: improves blood‑pressure control when monotherapy is insufficient High blood pressure in adults: contributes to decreased risk of cardiovascular events

Nobizide may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination - Mild electrolyte disturbances (e.g., low potassium) - Elevated blood glucose levels

Serious or Rare Side Effects: - Severe electrolyte imbalance (hypokalemia, hyponatremia) - Acute renal failure or significant rise in serum creatinine - Severe hypotension leading to syncope - Allergic reactions such as rash, angioedema, or anaphylaxis - Pancreatitis or severe abdominal pain

Before initiating therapy, clinicians should consider several safety measures.

Monitor electrolytes: check serum potassium and sodium regularly Assess renal function: evaluate creatinine clearance before and during therapy Measure blood pressure: ensure adequate control and avoid excessive hypotension Use caution in diabetes: diuretic component may affect glucose regulation Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension Store at room temperature: keep in original packaging, protect from moisture and light

Nobizide can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): may blunt diuretic effect and worsen renal function - Lithium: increased risk of lithium toxicity due to reduced clearance - Other antihypertensives (e.g., ACE inhibitors, ARBs): may cause excessive blood‑pressure lowering

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise nebivolol plasma levels - Potassium‑sparing diuretics or supplements: risk of hyperkalemia - Antidiabetic agents: diuretic‑induced changes in glucose may require dose adjustment